LONDON--Glaxo, the British pharmaceutical giant, plans to build a new research and development laboratory in Japan that would employ up to 300 scientists and support staff.
The center, to be completed by the early 1990s on the outskirts of Tokyo, will assume responsibility for drug trials in that country. The company’s investment in research rose by 51 percent in the second half of 1987, according to chairman Sir Paul Girolami.
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
